Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2005-003295-38Phase 4Completed
Phase 4, randomised trial of methylphenidate in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by Medice. Primary endpoint: SKAMP-D score during first three school lessons. Started Nov 2005; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2005-003295-38.